A33 antibody‐coated superparamagnetic nanoparticles bound to DOX‐loaded exosomes effectively targeted CRC cells, demonstrating enhanced tumor targeting, antiproliferative effects, reduced cardiotoxicity, and prolonged survival in vivo. Here, GPA33 is linked to neoplasm.